K. Woodman-Maynard is a Minneapolis-based comic artist and creator of graphic novel adaptations of “Tuck Everlasting” and ...
Heading into the 2026 J.P. Morgan Healthcare Conference, industry watchers are expecting the rise of China, the quantifiable ...
As the Oklahoma City Thunder continue to look like the NBA's best team and look ready to go back-to-back, Nikola Topic has made the most of his own journey. Topic remains out for the 2025-26 regular ...
Less than two months after his cancer diagnosis was announced, Nikola Topic of the Oklahoma City Thunder has made amazing on-court progress. Topic was at shootaround before Thursday’s game against the ...
Google today released its 2025 Year in Search list, but don’t mistake it for a ranking of the “top searches” or the “most searched” terms. This year’s recap focused on trending queries – the topics ...
Ethics of Artificial Hydration and Nutrition In Dementia Ethicist Art Caplan discusses a difficult case involving artificial feeding and hydration for a dementia patient.
Snapchat has introduced a new feature called “Topic Chats,” which allows users of the social network to participate in public conversations about popular trends. By its own admission, Snapchat has ...
After primarily focusing on private conversations since its founding, Snapchat is embracing public conversations with a new “Topic Chats” feature. The social network says the feature lets users chat ...
As the Oklahoma City Thunder continue to look like the NBA's undisputed best team, Nikola Topic has dealt with a personal matter away from the team. Sam Presti announced on Oct. 30 that he was ...
Nikola Topic, a guard for the NBA’s Oklahoma City Thunder, is undergoing chemotherapy treatment for testicular cancer, team leaders announced Thursday. Topic, 20, underwent a biopsy in Houston to ...
At Thursday's shoot-around, Sam Presti walked over to reporters to give an update on Rookie Guard Nikola Topic. The No.12 pick in the 2024 NBA Draft underwent a testicular procedure following the team ...
Nikola Topic, the Oklahoma City Thunder’s No. 12 pick in 2024, is undergoing chemotherapy to treat testicular cancer, team president Sam Presti announced Thursday. Topic, 20, was out since early in ...